FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034984669> ?p ?o ?g. }

• W2034984669 endingPage "1810" @default.
• W2034984669 startingPage "1810" @default.
• W2034984669 abstract "<h3>Importance</h3>Active perinatal care increases survival of extremely preterm infants; however, improved survival might be associated with increased disability among survivors.<h3>Objective</h3>To determine neurodevelopmental outcome in extremely preterm children at 2.5 years (corrected age).<h3>Design, Setting, and Participants</h3>Population-based prospective cohort of consecutive extremely preterm infants born before 27 weeks of gestation in Sweden between 2004 and 2007. Of 707 live-born infants, 491 (69%) survived to 2.5 years. Survivors were assessed and compared with singleton control infants who were born at term and matched by sex, ethnicity, and municipality. Assessments ended in February 2010 and comparison estimates were adjusted for demographic differences.<h3>Main Outcomes and Measures</h3>Cognitive, language, and motor development was assessed with Bayley Scales of Infant and Toddler Development (3rd edition; Bayley-lll), which are standardized to mean (SD) scores of 100 (15). Clinical examination and parental questionnaires were used for diagnosis of cerebral palsy and visual and hearing impairments. Assessments were made by week of gestational age.<h3>Results</h3>At a median age of 30.5 months (corrected), 456 of 491 (94%) extremely preterm children were evaluated (41 by chart review only). For controls, 701 had information on health status and 366 had Bayley-lll assessments. Mean (SD) composite Bayley-III scores (cognition, 94 [12.3]; language, 98 [16.5]; motor, 94 [15.9]) were lower than the corresponding mean scores for controls (cognition, 104 [10.6]; P < .001; adjusted difference in mean scores, 9.2 [99% CI, 6.9-11.5]; language, 109 [12.3]; P < .001; adjusted difference in mean scores, 9.3 [99% Cl, 6.4-12.3]; and motor, 107 [13.7]; P < .001; adjusted difference in mean scores, 12.6 [99% Cl, 9.5-15.6]). Cognitive disability was moderate in 5% of the extremely preterm group vs 0.3% in controls (P < .001) and it was severe in 6.3% of the extremely preterm group vs 0.3% in controls (P < .001). Language disability was moderate in 9.4% of the extremely preterm group vs 2.5% in controls (P < .001) and severe in 6.6% of the extremely preterm group vs 0% in controls (P < .001). Other comparisons between the extremely preterm group vs controls were for cerebral palsy (7.0% vs 0.1%; P < .001), for blindness (0.9% vs 0%; P = .02), and for hearing impairment (moderate and severe, 0.9% vs 0%; P = .02, respectively). Overall, 42% (99% CI, 36%-48%) of extremely preterm children had no disability, 31% (99% CI, 25%-36%) had mild disability, 16% (99% CI, 12%-21%) had moderate disability, and 11% (99% CI, 7.2%-15%) had severe disability. Moderate or severe overall disability decreased with gestational age at birth (22 weeks, 60%; 23 weeks, 51%; 24 weeks, 34%; 25 weeks, 27%; and 26 weeks, 17%; P for trend < .001).<h3>Conclusions and Relevance</h3>Of children born extremely preterm and receiving active perinatal care, 73% had mild or no disability and neurodevelopmental outcome improved with each week of gestational age. These results are relevant for clinicians counseling families facing extremely preterm birth." @default.
• W2034984669 created "2016-06-24" @default.
• W2034984669 creator A5013511786 @default.
• W2034984669 creator A5014823569 @default.
• W2034984669 creator A5030333540 @default.
• W2034984669 creator A5032337420 @default.
• W2034984669 creator A5039306834 @default.
• W2034984669 creator A5051004312 @default.
• W2034984669 creator A5051622169 @default.
• W2034984669 creator A5057141601 @default.
• W2034984669 creator A5059721848 @default.
• W2034984669 creator A5064439029 @default.
• W2034984669 creator A5066099568 @default.
• W2034984669 creator A5072448715 @default.
• W2034984669 creator A5073662614 @default.
• W2034984669 creator A5087489410 @default.
• W2034984669 creator A5089482537 @default.
• W2034984669 date "2013-05-01" @default.
• W2034984669 modified "2023-10-15" @default.
• W2034984669 title "Neurodevelopmental Outcome in Extremely Preterm Infants at 2.5 Years After Active Perinatal Care in Sweden" @default.
• W2034984669 cites W1547740703 @default.
• W2034984669 cites W1701664235 @default.
• W2034984669 cites W1949803408 @default.
• W2034984669 cites W1970638137 @default.
• W2034984669 cites W1978650103 @default.
• W2034984669 cites W1994779687 @default.
• W2034984669 cites W2013669949 @default.
• W2034984669 cites W2016274463 @default.
• W2034984669 cites W2017378691 @default.
• W2034984669 cites W2017835157 @default.
• W2034984669 cites W2020686017 @default.
• W2034984669 cites W2023349900 @default.
• W2034984669 cites W2029821195 @default.
• W2034984669 cites W2031964928 @default.
• W2034984669 cites W2038439560 @default.
• W2034984669 cites W2040681266 @default.
• W2034984669 cites W2054108871 @default.
• W2034984669 cites W2066356661 @default.
• W2034984669 cites W2067031234 @default.
• W2034984669 cites W2094443160 @default.
• W2034984669 cites W2101903842 @default.
• W2034984669 cites W2102806222 @default.
• W2034984669 cites W2105895381 @default.
• W2034984669 cites W2105984287 @default.
• W2034984669 cites W2110068092 @default.
• W2034984669 cites W2111422064 @default.
• W2034984669 cites W2112140599 @default.
• W2034984669 cites W2113996138 @default.
• W2034984669 cites W2114107525 @default.
• W2034984669 cites W2122833435 @default.
• W2034984669 cites W2126582489 @default.
• W2034984669 cites W2135089356 @default.
• W2034984669 cites W2136227605 @default.
• W2034984669 cites W2141088727 @default.
• W2034984669 cites W2155248348 @default.
• W2034984669 cites W2155652302 @default.
• W2034984669 cites W2159773378 @default.
• W2034984669 cites W2165251341 @default.
• W2034984669 cites W2171615840 @default.
• W2034984669 cites W2172167778 @default.
• W2034984669 cites W2319887059 @default.
• W2034984669 cites W2338619227 @default.
• W2034984669 doi "https://doi.org/10.1001/jama.2013.3786" @default.
• W2034984669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23632725" @default.
• W2034984669 hasPublicationYear "2013" @default.
• W2034984669 type Work @default.
• W2034984669 sameAs 2034984669 @default.
• W2034984669 citedByCount "429" @default.
• W2034984669 countsByYear W20349846692013 @default.
• W2034984669 countsByYear W20349846692014 @default.
• W2034984669 countsByYear W20349846692015 @default.
• W2034984669 countsByYear W20349846692016 @default.
• W2034984669 countsByYear W20349846692017 @default.
• W2034984669 countsByYear W20349846692018 @default.
• W2034984669 countsByYear W20349846692019 @default.
• W2034984669 countsByYear W20349846692020 @default.
• W2034984669 countsByYear W20349846692021 @default.
• W2034984669 countsByYear W20349846692022 @default.
• W2034984669 countsByYear W20349846692023 @default.
• W2034984669 crossrefType "journal-article" @default.
• W2034984669 hasAuthorship W2034984669A5013511786 @default.
• W2034984669 hasAuthorship W2034984669A5014823569 @default.
• W2034984669 hasAuthorship W2034984669A5030333540 @default.
• W2034984669 hasAuthorship W2034984669A5032337420 @default.
• W2034984669 hasAuthorship W2034984669A5039306834 @default.
• W2034984669 hasAuthorship W2034984669A5051004312 @default.
• W2034984669 hasAuthorship W2034984669A5051622169 @default.
• W2034984669 hasAuthorship W2034984669A5057141601 @default.
• W2034984669 hasAuthorship W2034984669A5059721848 @default.
• W2034984669 hasAuthorship W2034984669A5064439029 @default.
• W2034984669 hasAuthorship W2034984669A5066099568 @default.
• W2034984669 hasAuthorship W2034984669A5072448715 @default.
• W2034984669 hasAuthorship W2034984669A5073662614 @default.
• W2034984669 hasAuthorship W2034984669A5087489410 @default.
• W2034984669 hasAuthorship W2034984669A5089482537 @default.
• W2034984669 hasBestOaLocation W20349846691 @default.
• W2034984669 hasConcept C103728769 @default.
• W2034984669 hasConcept C114735433 @default.

• next